Loss of TGFBI induced specific resistance to paclitaxel in ovarian cancer cells, and paclitaxel-resistant cells treated with recombinant TGFBI protein show restoration of paclitaxel sensitivity (37). The gene discussed is TGFBI; the disease is ovarian cancer.